Health Press Release – Weekly Newsletter for February 7-14, 2011
Monday, February 14, 2011
The Sixth International Symposium on Molecular Insect Science to Feature Leading Researchers in the Field
Conference to be Held 2-5 October 2011, in the Netherlands
OXFORD, England, February 7, 2011 – Elsevier, the leading publisher of scientific, technical and medical
information products and services, announces that the Sixth International
Symposium on Molecular Insect Science is the first of the series to be held
outside the US. This year the conference will take place … Read the original article on Gaea Times at : The Sixth International Symposium on Molecular Insect Science to Feature Leading Researchers in the Field.
alli(R) Launching a New Chewable Tablet in 2011
LONDON, February 7, 2011 – GlaxoSmithKline (GSK) today announces that it has received a licence
extension for alli, the first pharmacy-only weight loss aid licensed for use
throughout Europe. This license extension is for new chewable tablets. The
new alli tablets are planned to be on sale in pharmacies throughout the UK in
April this year.
…. Read the original article : here.
Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans
LONDON, NEW YORK and HAMILTON, Bermuda, February 7, 2011 – — Transfersome(R) Trans-Dermal Delivery System potentiates terbinafine's
anti-fungal activity in TDT 067 –
Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma"), the global private
equity firm focused on the biotechnology and pharmaceutical industries,
announced today the presentation of key in-vitro data at the American Academy
of Dermatology …. Read the original article : Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans.
Astellas Enters into Partnership With Optimer on Life-Saving Antibiotic Fidaxomicin
Product Already Filed With European Medicines Agency
STAINES, England, February 7, 2011 – Astellas Pharma Europe Ltd. announced today that it has entered into an
exclusive collaboration and license agreement with Optimer Pharmaceuticals
Inc., San Diego for the development and commercialisation of fidaxomicin, an
investigational antibiotic for Clostridium difficile infection (CDI) in
Europe and certain other countries in the … Read the original article on Gaea Times at : Astellas Enters into Partnership With Optimer on Life-Saving Antibiotic Fidaxomicin.
LighterLife and the National Obesity Forum Launch The UK Obesity Barometer
HARLOW, England, February 7, 2011 – LighterLife and the National Obesity Forum have launched The UK Obesity
Barometer to track weight gain in the UK.
The UK Obesity Barometer shows that around 1.2 million people in the UK
moved into the 'overweight' or 'obese' category over the festive season*
pushing levels to a new … Read more : LighterLife and the National Obesity Forum Launch The UK Obesity Barometer.
Health Robotics Re-Enters the Italian Market With its World-Leading Robotics and Software Automation Tools
BOZEN, Sud-Tirol, Italy, February 7, 2011 – Health Robotics today announced that it recently decided to re-start
sales and service operations in Italy, after a three-year absence in
connection with a prior agreement with Gruppo Loccioni. With over 60 hospital
customers under contract carried forward from the company's 2006-2007
presence in the Italian market, Health Robotics is on …. Original source : Health Robotics Re-Enters the Italian Market With its World-Leading Robotics and Software Automation Tools.
Almac Opens Analytical Labs in New US Headquarters
SOUDERTON, Pennsylvania, February 7, 2011 – Almac's new 240,000 sq. ft. North American Headquarters, built on 40
acres in Souderton, PA, north of Philadelphia is part of the Almac Group's
integrated services solutions strategy. The new facility delivers
full-service, integrated clinical packaging, drug supply management and
technology solutions to pharmaceutical and biotech clients.
The facility [..] Read the original article: here.
ConvaTec Announces New Appointments to Leadership Team
Changes Align with Company's Commitment to Growth
SKILLMAN, New Jersey, February 7, 2011 – ConvaTec, a world-leading developer and marketer of innovative medical
technologies for community and hospital care, today announced the appointment
of several executives to new positions within the company.
Nino Pionati has been appointed President, Intercontinental in a newly
aligned region that … Read more >>>.
Fairfax Cryobank Announces Fairfax FaceMatch(TM) for Sperm Donors: Similar to System Used by the FBI, Computer Program Compares Photos to Find Resemblance
Fairfax Cryobank announces a new and exciting computer program to help patients "match" a photo of their partner or some other individual to find their perfect sperm donor
FAIRFAX, Virginia, February 7, 2011 – "Patients choosing donor sperm often wonder if they can find a donor who
resembles their partner or someone else. Fairfax Cryobank's new … Original article on : Fairfax Cryobank Announces Fairfax FaceMatch(TM) for Sperm Donors: Similar to System Used by the FBI, Computer Program Compares Photos to Find Resemblance.
PharmaMar Commences Clinical Trial in U.S. with New Antitumor Product, PM060184
PM060184 is a new marine-derived compound which has shown strong antitumor activity in preclinical models and a favorable safety profile in animal toxicology studies
MADRID, February 8, 2011 – PharmaMar SA (Grupo Zeltia, ZEL.MC) has announced the commencement of a
Phase I clinical trial with PM060184 for patients with solid tumors. PM060184
is a marine-derived synthetically-produced compound … Read more »».
NHS to Tackle Hospital Superbugs With Groundbreaking Irisys Infrared Technology
Solution Aims to Save Lives – and GBP1 Billion Every Year
LEAMINGTON SPA, England, February 8, 2011 – NHS figures show that about nine per cent of patients actually acquire
infections during a hospital stay. This costs the Health Service around
GBP1billion annually – money that could be saved by something as simple as
regular hand washing.
/C O R R E C T I O N – Virgin Active/
LONDON, February 8, 2011 – In the news release, "Spinning for the Upper Body From Virgin Active Health
Clubs" issued on 3 Feb 2011 14:12 GMT, by Virgin Active over PR Newswire, we
are advised by a representative of the company that In the news release
"Spinning for the Upper Body from Virgin Active Health Clubs", … Original article on : /C O R R E C T I O N — Virgin Active/.
One-Year European Registry Data Released for Popliteal Stenting With SUPERA(R)
Zero Fractures and Impressive Patency Results Reported for Unique Stent from IDEV Technologies
LEIPZIG, Germany, February 8, 2011 – Data from the Leipzig Registry tracking the results of patients treated
with the SUPERA(R) stent for peripheral arterial disease (PAD) of the
popliteal artery were reported during the recent 2011 Leipzig Interventional
Course (LINC). The SUPERA stent is CE … Original source on Gaea Times at : One-Year European Registry Data Released for Popliteal Stenting With SUPERA(R).
CID at JIM 2011
CID to Update Interventional Cardiologists on Cre8(TM) Drug Eluting Stent at the 2011 Joint Interventional Meeting
ROME, February 8, 2011 – CID spa, a European company leader in interventional medicine, will
present the key technologies implemented on CID's Cre8(TM) DES as well as all
the new preclinical data at the Joint Interventional Meeting (JIM) during the
Lunch Symposium …. Read the original article : CID at JIM 2011.
Core Children’s Services Launch New Website
BROMSGROVE, England, February 8, 2011 – Core Children's Services is pleased to announce the launch of its new
website to promote the broad range of services available for children, young
people and families across the UK.
In the midst of the changing climate within children and family services,
the new website addresses the ever-increasing … Read : Core Children's Services Launch New Website.
ALQAEM International to Make Noninvasive Glucose Monitor Available in the Region
DUBAI, United Arab Emirates, February 10, 2011 – The Health Care Division of ALQAEM International FZE, the
exclusive master distributor for the M.E.N.A. region of the UFIT(R)
noninvasive medical device created by Biosign Technologies Inc. of Canada, is
pleased to announce that it has placed orders for delivery this quarter and
will begin a limited release in March …. Source : ALQAEM International to Make Noninvasive Glucose Monitor Available in the Region.
Oncos Therapeutics Increases Clinical Momentum With Appointment of Chief Medical Officer
HELSINKI, February 9, 2011 – Oncos Therapeutics, a biotech company developing novel cancer
therapeutics based on its next generation oncolytic viruses, announced today
the appointment of Dr. Mikael von Euler, MD, PhD, FFPM, as Chief Medical
Officer. Earlier this year, the Company announced the appointments of Dr.
Jonathan Knowles and Dr. Robert Burns to its Board of Directors.
…. Source article : Oncos Therapeutics Increases Clinical Momentum With Appointment of Chief Medical Officer.
MarketsandMarkets: Global Injectable Drug Delivery Market To Be Worth $29,981 Million By 2015
DALLAS, February 9, 2011 – According to a new market research report, 'Global Injectable Drug
Delivery Market (2010 – 2015)', published by MarketsandMarkets
(www.marketsandmarkets.com), the global injectable drug delivery
market shows a significant growth potential and is expected to rise from
$14,994 million in 2009 to $29,981 million in 2015 at a CAGR of 12.3% during
2010-2015.
…. Original article : MarketsandMarkets: Global Injectable Drug Delivery Market To Be Worth $29,981 Million By 2015.
Frost & Sullivan Technology Innovation Award Conferred on AQTIS Medical BV for its Pioneering Ellanse(TM)
LONDON, February 9, 2011 – The 2011 Frost & Sullivan European Technology Innovation of the Year
Award in Dermal Fillers is presented to AQTIS Medical BV in recognition of
its pioneering Ellanse(TM).
(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
"This novel range of dermal fillers supports safe and cost-effective
treatments in aesthetic medicine and surgery, through … Read more >>.
Stop Proofreading – Start Bunnying! Schlafender Hase Releases New Version of the Text Verification Tool (TVT)
FRANKFURT, Germany, February 9, 2011 – Schlafender Hase ("sleeping hare") GmbH is not just changing the way the
pharmaceutical industry does proofreading. It is changing the word for
proofreading. "Have you 'bunnied' your text? That's the way one of our top US
customers asks if the proofreading process has been done," said Willie
Schnaubelt, managing director of Schlafender [..] Read the original article: here.
Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial
MOUNTAIN VIEW, California, February 9, 2011 – Concentric Medical, Inc. today announced that the first patients were
enrolled in TREVO 2 (Thrombectomy REvascularization of large Vessel
Occlusions) at Oregon Health & Science University in Portland, Oregon and at
Capital Health in Trenton, New Jersey. Oregon Health & Science enrolled the
first patient in TREVO 2 and Capital Health …. Original article on Gaea Times at : Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial.
ReportsnReports – The European Minimally Invasive Spinal Implant Markets Are Expected Exceed EUR90 Million By 2017
DALLAS, February 9, 2011 – ReportsnReports announces it will carry European Markets for Minimally
Invasive Spinal Devices 2011 Research Report in its store.
Browse the complete Report on:
www.reportsnreports.com/reports/59358-european-markets-for-minimally-i
nvasive-spinal-devices-2011.html
Search More Then 60000 Market Research Reports at
www.reportsnreports.com/
The European minimally invasive spinal implant markets are expected
exceed EUR90 …. Original source : ReportsnReports – The European Minimally Invasive Spinal Implant Markets Are Expected Exceed EUR90 Million By 2017.
Syngenta CEO Interviewed on New Strategy and 2010 Results
LONDON, February 9, 2011 – Syngenta, the world's largest agribusiness, says the decision to
integrate its Crop Protection and Seeds business would take the operations to
a "higher level of performance".
Earlier today in an interview with financial news website
www.cantos.com, Syngenta CEO Mike Mack said the first stages of the
integration would be complete …. Source : Syngenta CEO Interviewed on New Strategy and 2010 Results.
Torchmark Corporation Reports Fourth Quarter and Year-End 2010 Results
MCKINNEY, Texas, February 9, 2011 – Torchmark Corporation (NYSE: TMK) reported today that for the quarter
ended December 31, 2010, net income was $1.91 per share, compared with $1.36
per share for the year-ago quarter. Net operating income for the quarter was
$1.68 per share, compared with $1.47 per share for the year-ago quarter.
… Read : Torchmark Corporation Reports Fourth Quarter and Year-End 2010 Results.
Zebinix, Novel Once-Daily Anti-Epileptic Treatment, Launches in Spain
HATFIELD, England, February 10, 2011 – Zebinix(R) (eslicarbazepine acetate), an add-on (adjunctive) therapy for
adults with partial-onset seizures, with or without secondary generalisation
(where the seizure spreads to both sides of the brain), has been launched
today in Spain by Eisai and BIAL in a co-promotion.
In 2009, the European Commission approved Zebinix based …. Source : Gaea News Network.
Mobily Launches Mobile Baby(TM) Service for Transmitting Sonograms to Subscribers’ Mobile Phones
Mobily is the first mobile operator worldwide enabling parents to receive and send ultrasound scans wirelessly to their friends, family and loved ones
SAN DIEGO and RIYADH, Saudi Arabia, February 10, 2011 – Saudi Arabian telecommunications company Mobily and Great Connection
Inc., creator of the innovative Mobile Baby(TM) service, announced the launch
of the first mobile medical …. Original article : Mobily Launches Mobile Baby(TM) Service for Transmitting Sonograms to Subscribers' Mobile Phones.
MarketsandMarkets: Global Anesthesia and Respiratory Devices Market Worth US$12.7 Billion by 2015
DALLAS, February 10, 2011 – According to a new market research report, "Global Anesthesia and
Respiratory Devices Market (2010-2015)" published by MarketsandMarkets
(www.marketsandmarkets.com), the total global anesthesia and
respiratory devices market is expected to be worth US$12.7 billion by 2015,
out of which GE Healthcare will account for nearly 12% of the total revenues.
The global market is expected … Read more »»».
Pevion Appoints Didier Hoch, Former President of Sanofi Pasteur MSD, as Chairman of the Board
ITTIGEN, Switzerland and BERN, Switzerland, February 10, 2011 – Pevion Biotech Ltd. today announced the appointment of Didier
Hoch as Chairman of its Board of Directors. Until recently, Dr Hoch was
President of Sanofi-Pasteur MSD, where he played a pivotal role in launching
innovative vaccines, such as Gardasil(R), in Europe.
Prior to his position … Read more »».
Medivir Announces Start of Phase 1a Trial of the Hepatitis C Polymerase Inhibitor TMC649128
HUDDINGE, Sweden, February 10, 2011 – Medivir AB (OMX: MVIR), the emerging research-based specialty
pharmaceutical company focused on infectious diseases, today announces the
start of a phase 1a clinical trial with TMC649128 intended for the treatment
of chronic hepatitis C virus infection.
TMC649128 is a nucleoside NS5B polymerase inhibitor that has already
demonstrated an attractive …. Read the original article : Medivir Announces Start of Phase 1a Trial of the Hepatitis C Polymerase Inhibitor TMC649128.
Second Annual Latin America ‘Green Exchange Conference’ Hosted by Informex Focuses on a Sustainable Future for Chemistry
PRINCETON, New Jersey, February 10, 2011 – Informex (www.informex.com), the leading meeting place for buyers
and sellers of high-value chemistry for a broad range of applications, today
announced details of its second Latin American Green Exchange Conference,
which returns in 2011 to Sao Paulo, Brazil. The event will be held in
September 2011, with further details to be …. Source : Gaea News Network.
Novasep and instrAction Expand Alliance to Include Taxane Purification
Companies Will Develop Solutions to Change Manufacturing Paradigm for New and Generic Anti-cancer Compounds
POMPEY, France and LUDWIGSHAFEN, Germany, February 10, 2011 – Novasep, a leading supplier of manufacturing solutions to the
life science industries, and instrAction, a manufacturer of innovative
chromatographic stationary phases for API purification processes, today
announce they have expanded their worldwide strategic alliance to …. Read the original article : here.